Store
Histology and Cytology IVD Market Update, 2022
Publication Date: May 20, 2022
Tags: Diagnostic Instruments, Histology and Cytology, In Vitro Diagnostics (IVD)
Pages: 40
SKU: 22-035
Kalorama Information’s Histology and Cytology IVD Market Update report provides a comprehensive competitive analysis of the histology/cytology market from 2021 to 2026. Histology and cytology are crucial components of pathological labs, delivering vital information about cells, tissues, and organs, which are essential for diagnosing various diseases. Physicians depend heavily on these analyses for making informed decisions regarding cancer and other diseases, thereby shaping treatment plans and prognoses.
Key Insights:
- Market Analysis: Detailed examination of market trends, with forecasts extending to 2026.
- Technological Advancements: Insights into how advancements in digital imaging, quantitative microscopy, precision microscopy, artificial intelligence, and virtual histology are revolutionizing the industry.
- Segment Analysis: The market is segmented into five key areas:
- Traditional Non-PAP Stains
- PAP
- In Situ Hybridization
- Immunohistochemistry
- HPV
Featuring:
- Market Data: All market data pertains to the world market at the manufacturers’ level. The base year for data is 2021, with data projections provided for 2026, including compound annual growth rates (CAGRs) for the period.
- Regional Analysis: Market breakdowns for the United States, Europe, Asia-Pacific, and the Rest of the World.
- Analysis of market growth driven by demographic trends, new developments, innovative technology, and global expansion.
Competitive Landscape:
- Profiles and competitive analysis of five key market participants:
- Agilent
- Danaher
- Hologic
- Illumina
- Roche
Table: Global Histology/Cytology Sales, by Type, 2021-2026 (in millions $)
| Type | IVD Sales 2021 | % Mkt | IVD Sales 2026 | % Mkt | CAGR % |
| Pap tests | $XX Million | XX% | $XX Million | XX% | XX% |
| in situ hybridization | $XX Million | XX% | $XX Million | XX% | XX% |
| immunohistochemistry | $XX Million | XX% | $XX Million | XX% | XX% |
| traditional non-Pap stains | $XX Million | XX% | $XX Million | XX% | XX% |
| HPV – DNA | $XX Million | XX% | $XX Million | XX% | XX% |
| TOTAL | $XX Million | XX% | $XX Million | XX% | XX% |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
Chapter 1: Executive Summary
Industry at a Glance
Scope and Methodology
Size and Growth of the Market
- Figure 1-1: Global Histology IVD Market, 2021-2026 ($millions)
Competitive Outlook
Chapter 2: Market Analysis
Overview Of Histology/Cytology
Histology Market Segments
- Table 2-1: Global Histology/Cytology Sales by Type, 2021-2026 ($ millions) (Pap Tests, in situ hybridization, immunohistochemistry, traditional non-Pap stains, HPV, TOTAL)
- Figure 2-1: Histology/Cytology Diagnostic Market Distribution by Broad Test Category, 2021
Market Segment by Test Type
Traditional Tissue Stains
- Table 2-2: Selected Vendors of Traditional Histology Stains
PAP Tests
- Table 2-3: Primary and Secondary Prevention of Cervical Cancer, Screening Responses by Country, 2019 (last updated 2020-02-12)
Immunohistochemistry and In-Situ Hybridization
- Table 2-4: Selected in Situ Hybridization-based Tests
- Table 2-5: Selected IHC Test Innovations
HPV
- Figure 2-2: HPV Screening Market: HPV DNA and Pap Test Distribution of Sales, 2021
- Table 2-6: Global HPV Molecular (DNA/RNA) Test Sales Distribution by Region, 2021 (North America, Europe, Asia Pacific, RoW)
- Table 2-7: Selected HPV Test Innovations
Market by Region
- Table 2-8: Global Histology/Cytology Sales Distribution by Region, 2021 (%) (North America, Europe, Asia Pacific, RoW)
Competitive Analysis
- Table 2-9: Revenues of the Major Histology Companies, 2017-2021 ($ millions, estimated)
- Table 2-10: 2022 Pathology Launches by Roche
The Commercial Outlook for Histology
Chapter 3: Major Market Participants
Roche Diagnostic
- Table 3-1: Roche Diagnostic Corporate Summary
- Figure 3-1: Roche Diagnostics Revenue by Product Group, Full Year Results 2020, 2021, CHF MN
Danaher Corporation
- Table 3-2: Danaher Corporation Summary
- Figure 3-2: Danaher Diagnostic Segment Performance, Full Year Results, 2020,2021
Agilent
- Table 3-3: Agilent Corporate Summary
- Table 3-4: Agilent Revenues 2017-2021 (millions $)
Illumina, Inc
- Table 3-5: Illumina Corporate Summary
- Table 3-6: Illumina Diagnostics Revenues 2017-2021 (millions $)
Hologic
- Table 3-7: Hologic Corporate Summary
- Figure 3-3: Hologic Diagnostic Segment Performance, Full Year Results, FY 2020, FY 2021, $M
Related products
In Vitro Diagnostic (IVD) Trends and Market Update: November 2023
November 7, 2023
As in vitro diagnostic (IVD) testing returns to its vital role in healthcare, it remains a cornerstone in medical practice, providing crucial insights for physicians, from diagnosis to precision medicine. While COVID-19 testing sees a decline, it continues to influence total revenues for 2023. In this ever-changing landscape, characterized by new products, shifts in global…
Price range: $3,750.00 through $5,625.00
Clinical Laboratory Services Market, 8th Edition
May 18, 2023
Laboratories are the workhorse of diagnostic services for the IVD market. These laboratories play a vital role in providing analysis of a wide range of disorders and diseases including pathology, immunology, cholesterol testing, allergy testing, urinalysis, genetic testing and many more. Kalorama Information’s Clinical Laboratory Services Market, 8th Edition is your comprehensive resource for insights…
Price range: $4,000.00 through $6,000.00
30-Country IVD Market Atlas, 2024
December 23, 2024
With over two decades of experience in publishing in vitro diagnostic (IVD) market research, Kalorama Information presents the 30 Country In Vitro Diagnostics (IVD) Market Atlas, 2024. This quarterly updated report offers a unique approach focused on country-level research and analysis, providing a detailed analysis of major IVD segments forecasted for five years…
Price range: $5,000.00 through $7,875.00
